Dexcom, Inc., headquartered in San Diego, CA, is dedicated to developing innovative glucose sensing technology and products to help patients and healthcare providers better manage diabetes. The Dexcom G6â„˘ Continuous Glucose Monitoring (CGM) System does not require fingersticks for calibration or diabetes treatment decisions* and features simple, one-touch sensor insertion. The System provides exceptional accuracy with an overall MARD of 9.0%â€ and features an Urgent Low Soon alert that can warn users 20 minutes in advance of severe hypoglycemia (55 mg/dL). Dexcom is the only provider of CGM systems indicated for children ages 2 years and older. Please visit www.dexcom.com.
*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
â€ MARD is a statistical measure of accuracy; the lower the number, the better.
Ever since we introduced the first commercial insulin in 1923, Lilly Diabetes has been a global leader in diabetes care. Today, Lilly continues to develop innovative products, programs, and resources to help people with type 1 diabetes. For the past twelve years, Lilly has been a proud platinum sponsor of the Friends for LifeÂ® Orlando conference.
Join us at our booth to see all the ways we support the type 1 community and how your family can get involved. You can learn more about the role we play in diabetes camps and scholarships for everyday heroes with type 1, discover awards that acknowledge success in diabetes management, and be inspired by the achievements of NASCAR driver Ryan Reed in managing his type 1 diabetes. Youâ€™ll also be able to check out our popular books for families managing type 1 diabetes. They've been created in collaboration with Disney and explore real-life issues that affect families just like yours. Be sure to pick up your free copy of each of the Lilly Diabetes and Disney storybooks, featuring Coco the monkey.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its OmnipodÂ® product platform. The OmnipodÂ® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its OmnipodÂ® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insuletâ€™s OmnipodÂ® Insulin Management System to bring simplicity and freedom to their lives. For more information, visit www.myomnipod.com.
In 1923, the founders of Novo Nordisk began a journey to change diabetes. Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes. Novo Nordisk is proud to once again be a Platinum Level Sponsor of the Friends for Life® conference, supporting the Family and Friends Banquet and Sports Central. Please come see us at the exhibition to learn more about our type 1 support program, our new camp program and be among the first to learn about the first and only durable insulin pen with 0.5 unit doing and memory function - NovoPen Echo®. To learn more about Novo Nordisk and our support to the Type 1 diabetes community visit us at www.novonordisk-us.com.
Friends of CWD
Beta Bionics, Inc., is a Massachusetts public benefit corporation committed to commercializing and disseminating the iLetÂ®, a bionic pancreas for people living with T1D. Our stated benefit mission is (1) to provide a turnkey solution for safe and effective autonomous glycemic control, (2) to bring this technology to as many people with T1D as possible, (3) to continue to innovate and to offer the latest advances, and (4) to act in the best possible interest of the T1D community. As a benefit corporation founded by parents of children with T1D, Beta Bionics, unlike any other medical technology company, is protected under Massachusetts law to prioritize its benefit mission and place the best interests of the T1D community ahead of all other considerations. Beta Bionics is pleased to be a sponsor of Friends for LifeÂ®. To learn more about Beta Bionics, the iLet, and our public benefit mission, visit us at www.betabionics.org and @BetaBionics on social media.
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal. In addition to our research funding and leadership, JDRFâ€™s outreach efforts provide practical support and resources for people with T1D and their families every step of the way as they live with T1D. JDRF is proud to partner with Children with Diabetes by sponsoring regional and national conferences as a charity partner, and supporting sessions at Friends for Life®. For more information, visit the JDRF website at www.jdrf.org, or call 800-533-CURE.
Since 1985, the Pediatric-Adolescent Diabetes Research and Education (PADRE) Foundation has been dedicated to improving the lives of the youth and families living with Type 1 diabetes by providing exceptional education, support and events for all children with diabetes, as well as for their parents and siblings. We believe we can inspire kids to lead AMAZING lives until a cure for Type 1 diabetes is found. For more information, visit the PADRE Foundation website at www.padrefoundation.org or call 714-509-8330.
Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem manufactures and sells the t:slim X2â„˘ Insulin Pump, the only pump capable of remote feature updates using a personal computer, and the t:flexÂ® Insulin Pump, the first pump designed for people with greater insulin requirements. Tandem is based in San Diego, California.
[ Report | Photos | Sponsors ]
|Return to the Top of This Page|
Last Updated: Monday August 06, 2018 14:07:03
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.